Administration of Subcutaneous IL-2 is Associated with Strong Induction of Regulatory T Cells in High-Risk Neuroblastoma Patients Treated with Dinutuximab Beta, A SIOPEN Study

PEDIATRIC BLOOD & CANCER(2019)

Cited 1|Views5
No score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined